title: Peritoneal mesothelioma.
abstract: Peritoneal disease accounts for just under a third of all malignant mesothelioma. Its insidious onset means that diagnosis is often made at an advanced stage, however, new therapeutic techniques are starting to lead to improved outcomes.
authors.affiliation: University Hospital of Llandough, Cardiff, UK.
authors.forename: James
authors.initials: J
authors.lastname: Berrill
authors.forename: Hasan
authors.initials: H
authors.lastname: Haboubi
authors.forename: Paul
authors.initials: P
authors.lastname: Duane
mesh_terms: D001194:Asbestos / Q000009:adverse effects*; D001201:Ascites / Q000209:etiology; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D019016:Mineral Fibers / Q000009:adverse effects; D010534:Peritoneal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
chemical_list: D019016:Mineral Fibers; D001194:Asbestos